carteolol has been researched along with sq-11725 in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (44.44) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Amano, H; Kubo, T; Kuwahara, M; Misu, Y | 1 |
Glassman, HN; Jordan, DC; Luther, RR | 1 |
Abiko, Y; Ichihara, K | 1 |
Horinouchi, T; Koike, K | 1 |
1 review(s) available for carteolol and sq-11725
Article | Year |
---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
1 trial(s) available for carteolol and sq-11725
Article | Year |
---|---|
A comparison of carteolol and nadolol in the treatment of stable angina pectoris.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Carteolol; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Nadolol; Propanolamines; Random Allocation | 1988 |
7 other study(ies) available for carteolol and sq-11725
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A trial for kinetic evaluation of the antagonistic potency of several beta-antagonists on presynaptic beta-adrenoceptors.
Topics: Adrenergic beta-Antagonists; Animals; Carteolol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Kinetics; Male; Nadolol; Norepinephrine; Pindolol; Propranolol; Pulmonary Artery; Receptors, Adrenergic, beta | 1987 |
Cardiac metabolism as an indicator of oxygen supply/demand ratio.
Topics: Animals; Calcium Channel Blockers; Carteolol; Dogs; Female; Fructosediphosphates; Fructosephosphates; Glucose-6-Phosphate; Glucosephosphates; Heart; In Vitro Techniques; Male; Myocardium; Nadolol; Oxygen Consumption; Propranolol | 1988 |
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |